To NASDAQ OMX Copenhagen A/S
Announcement no. 16-14 / Copenhagen, July 1, 2014
Pursuant to the Danish Securities Trading Act, Section 28a this is to report the following transactions by members of Topotarget A/S’ board of directors and senior management as well as their related parties concerning shares issued by Topotarget A/S and related securities.
| Name | Bo Jesper Hansen |
| Reason for reporting | Chairman of the board of directors |
| Issuer and ISIN code | Topotarget A/S, DK0060003556 |
| Transaction | Subscription of shares through exercise of warrants |
| Trade Date | July 1, 2014 |
| Market | Nasdaq OMX, Copenhagen |
| Number of shares | 200,000 |
| Market value in DKK | DKK 554,500 based on an average subscription price of DKK 2.775 per share |
| Name | Anker Lundemose |
| Reason for reporting | Board member |
| Issuer and ISIN code | Topotarget A/S, DK0060003556 |
| Transaction | Subscription of shares through exercise of warrants |
| Trade Date | July 1, 2014 |
| Market | Nasdaq OMX, Copenhagen |
| Number of shares | 100,000 |
| Market value in DKK | DKK 277,500 based on an average subscription price of DKK 2.775 per share |
| Name | Gisela Schwab |
| Reason for reporting | Board member |
| Issuer and ISIN code | Topotarget A/S, DK0060003556 |
| Transaction | Subscription of shares through exercise of warrants |
| Trade Date | July 1, 2014 |
| Market | Nasdaq OMX, Copenhagen |
| Number of shares | 75,000 |
| Market value in DKK | DKK 189,500 based on an average subscription price of DKK 2.526 per share |
| Name | Ingelise Saunders |
| Reason for reporting | Board member |
| Issuer and ISIN code | Topotarget A/S, DK0060003556 |
| Transaction | Subscription of shares through exercise of warrants |
| Trade Date | July 1, 2014 |
| Market | Nasdaq OMX, Copenhagen |
| Number of shares | 113,769 |
| Market value in DKK | DKK 321,561 based on an average subscription price of DKK 2.826 per share |
| Name | Jeffrey Buchalter |
| Reason for reporting | Board member |
| Issuer and ISIN code | Topotarget A/S, DK0060003556 |
| Transaction | Subscription of shares through exercise of warrants |
| Trade Date | July 1, 2014 |
| Market | Nasdaq OMX, Copenhagen |
| Number of shares | 113,769 |
| Market value in DKK | DKK 321,561 based on an average subscription price of DKK 2.826 per share |
| Name | Karsten Witt |
| Reason for reporting | Board member |
| Issuer and ISIN code | Topotarget A/S, DK0060003556 |
| Transaction | Subscription of shares through exercise of warrants |
| Trade Date | July 1, 2014 |
| Market | Nasdaq OMX, Copenhagen |
| Number of shares | 75,000 |
| Market value in DKK | DKK 189,500 based on an average subscription price of DKK 2.526 per share |
| Name | Anders Fink Vadsholt |
| Reason for reporting | CEO |
| Issuer and ISIN code | Topotarget A/S, DK0060003556 |
| Transaction | Subscription of shares through exercise of warrants |
| Trade Date | July 1, 2014 |
| Market | Nasdaq OMX, Copenhagen |
| Number of shares | 650,000 |
| Market value in DKK | DKK 1,807,500 based on an average subscription price of 2.7807 per share |
Topotarget A/S
For further information, please contact:
Anders Vadsholt, CEO – direct: +45 39178345
Background information
About Topotarget
Topotarget (NASDAQ OMX: TOPO) is a Danish-based biopharmaceutical company headquartered in Copenhagen, Denmark, dedicated to the clinical development and registration of oncology products. In collaboration with Spectrum Pharmaceuticals, Inc., Topotarget focuses on the development of its lead drug candidate, belinostat, which has shown positive results in the treatment of hematological malignancies and solid tumors, obtained by both mono- and combination therapy. For more information, please refer to www.topotarget.com.
Topotarget Safe Harbor Statement
This announcement may contain forward-looking statements, including statements about Topotarget A/S’ expectations to the progression of Topotarget A/S’ clinical pipeline and with respect to cash burn guidance. Such statements are subject to risks and uncertainties of which many are outside the control of Topotarget A/S, and which could cause actual results to differ materially from those described. Topotarget A/S disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by Danish law.
